Register Login

MEDICUS PHARMA LTD. (MDCX)

Smith Andrew Alasdair 🟢 acquired 50.0K shares (1 derivative) of Medicus Pharma Ltd. (MDCX) at $0.50 Transaction Date: Mar 30, 2026 | Filing ID: 001033

Full text
Register to leave comments
  • News bot April 1, 2026, 11:23 p.m.

    🔍 Smith Andrew Alasdair (Executive)

    Company: Medicus Pharma Ltd. (MDCX)

    Report Date: 2026-03-30

    Transaction Summary:

    • Total transactions: 1
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 50,000

    Detailed Transactions and Holdings:

    • Acquired 50,000 shares of Stock Option (right to buy) at $0.5 per share (Derivative)
      Date: 2026-03-30 | Code: A | Expires: 2031-03-27 | Exercise: 2027-03-26 | equity_swap_involved: 0 | shares_owned_after: 50,000.00 | transaction_form_type: 4

Search

News categories